Resources  /  Treatments

Compounded vs registered medicines: the difference that matters

They can contain the same molecule. What differs is who assessed it, what was proven, and who is accountable if it is wrong.

Educational — not a recommendation to take anything

The difference is not the molecule

A compounded preparation and a registered medicine can contain the same active ingredient. What differs is everything around it: who assessed it, what was proven before it reached you, and who is accountable if something is wrong.

Both are legal in Costa Rica. Confusing them is how people get hurt.

What registration means

A registered medicine has been through a sanitary registration process. A dossier was assessed — manufacturing quality, stability, safety, efficacy — and the product carries a registration number that can be checked.

It is made under pharmaceutical manufacturing standards, in batches that are tested and traceable. If a batch is faulty it can be recalled, because the regulator knows it exists.

That is what the Ministry's October 2025 warning was pointing at when it required that patients be told the brand, the active ingredient and the registration number. Three facts, checkable, and the difference between a medicine and a preparation.

What magistral preparation means

Preparación magistral is a licensed pharmacy making a medicine for one named patient against one individual prescription. It is a legitimate and old part of pharmacy, and it exists for real reasons: a dose that is not manufactured, an allergy to an excipient, a formulation a child can take, a product discontinued commercially.

Costa Rica's July 2026 health warning restated the boundary explicitly. Compounding is permitted for a named patient. What is prohibited is manufacturing to hold inventory, commercialising at scale, and advertising the compounded product to the public.

So the legitimate version is a pharmacy responding to a prescription. The illegitimate version is a catalogue.

The three questions that separate them

  1. Was it made for me, by name, against my prescription? If it was made in advance and held in stock, it is not magistral preparation whatever it is called.
  2. Which pharmacy made it, and is it licensed for this? Sterile injectable preparation is a different capability from compounding a cream. It requires clean rooms and specific standards, and not every pharmacy has them.
  3. Can anyone tell me what is actually in it, and how it was tested? A compounded product has no registration dossier behind it. The quality assurance is the pharmacy's own.

What you give up

Being clear about this is not an argument against compounding — it is what the patient is accepting:

  • No efficacy dossier. Nobody assessed whether this preparation works as intended.
  • No stability data of the kind registration requires. How long it lasts and under what storage is the compounder's assertion.
  • Batch‑to‑batch variability is inherently greater than in industrial manufacture.
  • Harder recall. If something is wrong, there is no registered batch to withdraw.

Where the registered product exists and is available, those are real costs for no obvious gain. Where no registered product can meet the need, they may be worth accepting with eyes open.

The category that is neither

Worth separating out, because it is the one causing harm. A substance that is not registered anywhere and is not being compounded for a named patient is neither of the things on this page.

The July 2026 warning named retatrutide, tesamorelin, BPC‑157, TB‑500 and GHK‑Cu in this context. Material sold with "research use only" on the label, or ordered from abroad without a prescription, sits here. The label is not a formality: it means no regulator has assessed it for human use, and the seller is explicitly saying so.

Why a clinic's arrangement matters

If a clinic both prescribes a compounded preparation and profits from the pharmacy that makes it, that is a commercial arrangement you should be told about. Such arrangements are common and not automatically improper — what matters is disclosure, and that it cannot influence what is prescribed or how much.

Ask directly. A clinic that answers plainly is easier to trust than one with no answer ready.

The boundary

Whether a compounded preparation is appropriate for you is a clinical judgement, and sometimes it genuinely is. The questions above are how you tell which situation you are in — and a provider who cannot answer them has told you something useful.

Measure it rather than guess

Every patient starts the same way: thirty minutes with a physician, then a full biomarker panel drawn at a laboratory near you. Whether any medicine follows is your doctor’s decision, made after reading your results with you.

Measure my biomarkers